Ractigen Therapeutics Alternatives & Competitors
12 companies similar to Ractigen Therapeutics — Turn on genes and turn off diseases
Nuvamid
A clinical stage biotech focused on the research and use of nucleotides, as therapeutics f...
Nyon, Switzerland
Harness Therapeutics
Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases
Cambridge, United Kingdom
Affinia Therapeutics
Building the next generation of gene therapies
Waltham, United States
Rocket Pharmaceuticals
Seeking gene therapy cures
Cranbury, United States
Track all Ractigen Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Alnylam Pharmaceuticals
Alnylam is the leading RNAi therapeutics company. We're a fast-growing biopharma with a de...
Cambridge, United States
Bloomsbury Genetic Therapies
Dedicated to delivering the promise of gene therapy
London, United Kingdom
MoglingBio Inc
Rejuvenation of stem cells
United States
Ipsen
Engineers and develops bacterial-based protein therapeutics for the treatment of neurologi...
Paris, France
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
Cambridge, United States
Prellis Biologics
Integrating human biology with machine learning for antibody discovery
Berkeley, United States
Immusoft
Cell therapy company dedicated to improving the lives of patients with rare diseases
Seattle, United States
Solid Biosciences
#TogetherWeAreSolid
Boston, United States
About Ractigen Therapeutics
Turn on genes and turn off diseases
Development of saRNA therapeutics, Gene activation technology, Clinical-stage drug development, Research and development in RNAa
Biotech companies, Pharmaceutical companies, Academic researchers, Medical professionals, Patients with undruggable diseases
Biotech, Clinical Stage, Gene Therapy, RNA Activation, RNAa, Therapeutic Gene Expression, Disease Treatment, Novel Therapies, Oligonucleotide Therapeutics, SaRNA Drugs, Gene Silencing, Unmet Medical Needs, UCSF Discovery, Biopharmaceutical Pipeline, First-in-class Therapies
B2B, D2C
Licensing, Product Sales, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Ractigen Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Ractigen Therapeutics on 3 Apr 2026. The 12 companies listed here were last checked between 26 Nov 2025 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.